SMTL ID : 5ob5.1

fAb complex with GroBeta. AbVance: increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.65 Å

Oligo State

hetero-1-1-1-mer

Ligands

4 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 8 residues within 4Å: Chain A: E.1, L.2, R.3 Chain B: R.103 Chain C: H.91, G.92, E.93, S.94 6 PLIP interactions: 1 interactions with chain C, 3 interactions with chain A, 2 interactions with chain B Hydrogen bonds: C:G.92, A:L.2, A:L.2, A:R.3, B:R.103, B:R.103 GOL.2: 11 residues within 4Å: Chain B: F.172, P.173, A.174, V.175, S.183, L.184, S.185 Chain C: Q.160, S.162, S.176, T.178 7 PLIP interactions: 3 interactions with chain B, 4 interactions with chain C Hydrogen bonds: B:P.173, B:V.175, B:S.185, C:Q.160, C:S.176, C:S.176, C:T.178 GOL.6: 7 residues within 4Å: Chain B: V.169, H.170 Chain C: T.164, E.165, Q.166, D.167, S.168 8 PLIP interactions: 5 interactions with chain C, 3 interactions with chain B Hydrogen bonds: C:S.168, C:S.168, B:H.170 Water bridges: C:T.164, C:E.165, C:S.168, B:T.171, B:T.171 GOL.7: 4 residues within 4Å: Chain B: P.129 Chain C: S.121, D.122, E.123 5 PLIP interactions: 5 interactions with chain C Hydrogen bonds: C:D.122, C:D.122, C:E.123 Water bridges: C:E.123, C:E.123

3 x SO4: SULFATE ION(Non-functional Binders)

SO4.3: 4 residues within 4Å: Chain B: G.56, Y.57, T.58, R.72 8 PLIP interactions: 8 interactions with chain B Hydrogen bonds: B:G.56, B:T.58 Water bridges: B:T.58, B:T.58, B:R.72, B:R.72, B:R.72 Salt bridges: B:R.72 SO4.4: 2 residues within 4Å: Chain B: H.108, W.109 7 PLIP interactions: 6 interactions with chain B, 1 interactions with chain C Hydrogen bonds: B:W.109 Water bridges: B:A.107, B:H.108, B:H.108, B:W.109, C:L.46 Salt bridges: B:H.108 SO4.5: 3 residues within 4Å: Chain B: V.2, R.98, H.108 4 PLIP interactions: 4 interactions with chain B Water bridges: B:R.98, B:R.98 Salt bridges: B:R.98, B:H.108

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Convery, M.A., AbVance: increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery. To Be Published

Release Date

2017-11-08

Peptides

C-X-C motif chemokine 2: A
fAb Heavy chain: B
fAb Light chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
H

C
L

C-X-C motif chemokine 2

fAb Heavy chain

fAb Light chain